Union Bancaire Privee UBP SA Takes $67,000 Position in Lemonade, Inc. (NYSE:LMND)

Union Bancaire Privee UBP SA bought a new position in Lemonade, Inc. (NYSE:LMNDFree Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 1,745 shares of the company’s stock, valued at approximately $67,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in LMND. Avior Wealth Management LLC acquired a new position in shares of Lemonade in the fourth quarter valued at about $40,000. KBC Group NV purchased a new stake in Lemonade in the fourth quarter valued at approximately $80,000. Blue Trust Inc. increased its holdings in Lemonade by 220.0% in the 3rd quarter. Blue Trust Inc. now owns 2,733 shares of the company’s stock worth $45,000 after buying an additional 1,879 shares during the period. Point72 Asia Singapore Pte. Ltd. raised its position in Lemonade by 321.3% during the 3rd quarter. Point72 Asia Singapore Pte. Ltd. now owns 4,462 shares of the company’s stock worth $74,000 after buying an additional 3,403 shares during the last quarter. Finally, Johnson & White Wealth Management LLC acquired a new stake in Lemonade during the 4th quarter valued at approximately $234,000. Institutional investors and hedge funds own 80.30% of the company’s stock.

Insider Activity

In other Lemonade news, major shareholder Softbank Group Capital Ltd sold 719,815 shares of the stock in a transaction that occurred on Monday, December 16th. The stock was sold at an average price of $44.29, for a total transaction of $31,880,606.35. Following the completion of the transaction, the insider now owns 11,263,569 shares of the company’s stock, valued at $498,863,471.01. This represents a 6.01 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider John Sheldon Peters sold 28,985 shares of the firm’s stock in a transaction that occurred on Monday, December 30th. The shares were sold at an average price of $38.67, for a total value of $1,120,849.95. Following the completion of the transaction, the insider now owns 69,508 shares in the company, valued at approximately $2,687,874.36. This trade represents a 29.43 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 769,657 shares of company stock worth $33,868,724 in the last quarter. Corporate insiders own 12.50% of the company’s stock.

Lemonade Stock Performance

Shares of Lemonade stock opened at $32.18 on Wednesday. The firm has a 50-day simple moving average of $35.42 and a two-hundred day simple moving average of $29.17. Lemonade, Inc. has a fifty-two week low of $14.03 and a fifty-two week high of $53.85. The company has a market cap of $2.30 billion, a P/E ratio of -10.58 and a beta of 2.15.

Lemonade (NYSE:LMNDGet Free Report) last released its quarterly earnings results on Tuesday, February 25th. The company reported ($0.42) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.61) by $0.19. Lemonade had a negative return on equity of 32.85% and a negative net margin of 43.51%. Equities research analysts forecast that Lemonade, Inc. will post -3.03 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on LMND shares. Morgan Stanley upgraded shares of Lemonade from an “underweight” rating to an “equal weight” rating and increased their price objective for the stock from $23.00 to $42.00 in a research note on Wednesday, November 20th. JMP Securities increased their price target on Lemonade from $40.00 to $60.00 and gave the stock a “market outperform” rating in a research report on Friday, November 22nd. Keefe, Bruyette & Woods lowered Lemonade from a “market perform” rating to an “underperform” rating and lifted their price objective for the company from $18.00 to $21.00 in a research note on Thursday, November 7th. BMO Capital Markets upped their target price on Lemonade from $13.00 to $15.00 and gave the stock an “underperform” rating in a research note on Thursday, November 21st. Finally, Piper Sandler lifted their price target on Lemonade from $25.00 to $44.00 and gave the company a “neutral” rating in a research report on Thursday, November 21st. Three research analysts have rated the stock with a sell rating, two have given a hold rating and one has assigned a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $32.67.

Get Our Latest Analysis on LMND

Lemonade Profile

(Free Report)

Lemonade, Inc provides various insurance products through various channels in the United States, Europe, and the United Kingdom. Its insurance products include stolen or damaged property, and personal liability that protects its customers if they are responsible for an accident or damage to another person or their property.

Read More

Institutional Ownership by Quarter for Lemonade (NYSE:LMND)

Receive News & Ratings for Lemonade Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lemonade and related companies with MarketBeat.com's FREE daily email newsletter.